Journal article
Role of Lipoprotein Apheresis in Cardiovascular Disease Risk Reduction
Abstract
BACKGROUND AND AIM: Elevated low-density lipoprotein cholesterol and/or lipoprotein(a) are established risk factors for cardiovascular disease (CVD). Management of hypercholesterolemia consists of drug therapies, including statins and proprotein convertase subtilisin/kexin type 9 inhibitors. In patients with familial hypercholesterolemia (FH), lipoprotein apheresis (LA) is utilized to control lipid levels. However, LA is not currently a …
Authors
Raina R; Young C; Krishnappa V; Chanchlani R
Journal
Blood Purification, Vol. 47, No. 4, pp. 301–316
Publisher
Karger Publishers
Publication Date
2019
DOI
10.1159/000497447
ISSN
0253-5068